Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intestinal Microbiota on Treatment Sensitivity and Prognosis of Methimazole for GD

NCT03433352 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT03433352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intestinal Microbiota on Treatment Sensitivity and Prognosis of Methimazole for GD
Lead sponsor
First Affiliated Hospital of Harbin Medical University
Phase
Observational
Overall status
Unknown status
Start date
December 23, 2017
Completion date
December 20, 2019
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microbiota